Filter the latest scan's published facts — sector, size, yield, valuation — or rank them with a preset: cheapest, fastest growing, most profitable. Every view shows what is in the filings and prices; none ranks opportunity. The model behind the statuses showed no predictive power, and nothing here is a recommendation.
Scan of 2026-08-31 · 2,409 names scored · prices as of that date
Lowest valid-in-sector trailing valuation multiples today, latest scan: each name's sector percentiles on earnings yield, FCF yield, P/S, P/B, P/TBV and P/CFO, averaged (only the metrics valid in its sector — a REIT is never ranked by GAAP P/E here). “Cheapest” is a fact about trailing multiples versus sector peers, not a forecast that they re-rate.
Tested the unforgiving way: a composite ranking built from these same point-in-time filings (2017-01-31 to 2026-05-29) showed no measurable predictive power (mean IC 0.0168, t = 1.21), and its top quintile did not beat holding everything even before costs. Ranks like these describe today's record; they do not predict tomorrow's return.
180 names — page 3 of 4 · sector: Healthcare · Export CSV
| # | Ticker | Company | Sector | Cheap composite | P/E (trailing) | P/S (trailing) | FCF yield | Own 5y |
|---|---|---|---|---|---|---|---|---|
| 101 | SYK | Stryker Corporation | Healthcare | 47.8 | 37.2× | 4.9× | 3.7% | +2.2σ |
Never the absolute multiple alone. A P/E of 9 is a fact; whether it is low depends on what you hold it against.
The five-year window is the empirically privileged one. Cheap against its sector and cheap against its own history are different claims, and a stock can be one without being the other — which is the whole reason both columns are shown rather than blended into a single score.
| 102 | STAA | Staar Surgical Co | Healthcare | 46.2 | — | 3.9× | -4.9% | −2.4σ |
| 103 | LNSR | LENSAR, Inc. Common Stock | Healthcare | 45.5 | 3.5× | 2.0× | -12.1% | +0.5σ |
| 104 | RAL | Ralliant Corporation | Healthcare | 45.2 | — | 3.3× | 4.4% | — |
| 105 | AME | Ametek, Inc. | Healthcare | 43.9 | 35.5× | 7.1× | 3.1% | −1.2σ |
| 106 | DCTH | Delcath Systems Inc | Healthcare | 43.9 | — | 6.3× | 3.4% | +1.1σ |
| 107 | ANGO | AngioDynamics, Inc. | Healthcare | 43.6 | — | 2.1× | -1.8% | +0.4σ |
| 108 | GRMN | Garmin Ltd | Healthcare | 43.1 | 31.6× | 7.3× | 2.6% | −1.0σ |
| 109 | ALNT | Allient Inc. Common Stock | Healthcare | 42.6 | — | 2.9× | 2.5% | −0.3σ |
| 110 | UFPT | UFP Technologies Inc | Healthcare | 42.3 | 33.6× | 3.8× | 3.1% | +0.6σ |
| 111 | PRCT | PROCEPT BioRobotics Corporation Common Stock | Healthcare | 41.5 | — | 3.7× | -6.7% | −1.4σ |
| 112 | HIMS | Hims & Hers Health, Inc. | Healthcare | 41.4 | — | 2.9× | 4.1% | +1.1σ |
| 113 | SHC | Sotera Health Company Common Stock | Healthcare | 40.8 | 45.8× | 4.5× | 1.8% | +0.3σ |
| 114 | ASTC | Astrotech Corporation (DE) Common Stock | Healthcare | 40.7 | — | 12.5× | -113.3% | −0.5σ |
| 115 | COHU | Cohu Inc | Healthcare | 40.7 | — | 4.8× | 1.7% | −0.5σ |
| 116 | TMO | Thermo Fisher Scientific, Inc. | Healthcare | 40.3 | 40.1× | 6.1× | 2.5% | −1.3σ |
| 117 | BRKR | Bruker Corporation | Healthcare | 39.9 | — | 2.6× | 0.6% | −2.0σ |
| 118 | MASS | 908 Devices Inc. Common Stock | Healthcare | 39.9 | — | 6.9× | -2.1% | +1.4σ |
| 119 | DXCM | DexCom, Inc. | Healthcare | 39.8 | 37.8× | 7.3× | 4.1% | +1.8σ |
| 120 | MMM | 3M Company | Healthcare | 39.3 | 32.2× | 3.6× | 2.3% | −0.9σ |
| 121 | INNV | InnovAge Holding Corp. Common Stock | Healthcare | 39.2 | — | 1.5× | 2.5% | +1.0σ |
| 122 | IMAX | Imax Corp | Healthcare | 39.1 | 76.4× | 6.9× | 4.1% | +0.6σ |
| 123 | PRPO | Precipio, Inc. Common Stock | Healthcare | 38.1 | — | 1.9× | 1.1% | +1.0σ |
| 124 | WRBY | Warby Parker Inc. | Healthcare | 37.7 | — | 3.4× | 1.3% | +0.8σ |
| 125 | TT | Trane Technologies plc | Healthcare | 37.7 | 37.5× | 5.0× | 2.8% | +0.1σ |
| 126 | BBNX | Beta Bionics, Inc. Common Stock | Healthcare | 37.2 | — | 8.1× | -6.9% | — |
| 127 | EW | Edwards Lifesciences Corp | Healthcare | 37.1 | 47.8× | 8.3× | 2.1% | +0.5σ |
| 128 | A | Agilent Technologies Inc. | Healthcare | 37.0 | 30.6× | 6.0× | 2.3% | −1.6σ |
| 129 | GRAL | GRAIL, Inc. Common Stock | Healthcare | 36.2 | — | 20.9× | -9.0% | — |
| 130 | SI | Shoulder Innovations, Inc. | Healthcare | 36.1 | — | 8.1× | -10.1% | — |
| 131 | SIBN | SI-BONE, Inc. Common Stock | Healthcare | 35.5 | — | 4.1× | -0.7% | +1.6σ |
| 132 | NVCR | NovoCure Limited Ordinary Shares | Healthcare | 34.8 | — | 3.0× | -2.4% | +0.1σ |
| 133 | ATRC | AtriCure, Inc. | Healthcare | 34.8 | — | 4.4× | 2.2% | +1.6σ |
| 134 | ROK | Rockwell Automation, Inc. | Healthcare | 34.6 | 44.0× | 5.4× | 2.6% | −0.4σ |
| 135 | WST | West Pharmaceutical Services, Inc. | Healthcare | 34.5 | 44.6× | 7.5× | 1.9% | +0.6σ |
| 136 | WAT | Waters Corp | Healthcare | 34.3 | 90.5× | 10.8× | 0.6% | −3.2σ |
| 137 | MKSI | MKS Inc. Common Stock | Healthcare | 33.7 | 52.7× | 4.2× | 2.3% | −1.5σ |
| 138 | AVR | Anteris Technologies Global Corp. Common Stock | Healthcare | 33.6 | — | 452× | -10.4% | — |
| 139 | ISRG | Intuitive Surgical Inc. | Healthcare | 32.8 | 44.8× | 12.6× | 2.1% | +1.9σ |
| 140 | OMDA | Omada Health, Inc. Common Stock | Healthcare | 32.4 | — | 5.1× | 1.5% | — |
| 141 | CDNA | CareDx, Inc. | Healthcare | 32.0 | — | 6.2× | 2.8% | +1.0σ |
| 142 | CGNX | Cognex Corp | Healthcare | 31.9 | 71.2× | 9.7× | 2.4% | +0.1σ |
| 143 | CARL | Carlsmed, Inc. Common Stock | Healthcare | 31.3 | — | 7.8× | -7.8% | — |
| 144 | PEN | Penumbra, Inc. | Healthcare | 29.4 | 74.1× | 8.7× | 1.7% | +1.3σ |
| 145 | TNDM | Tandem Diabetes Care, Inc. | Healthcare | 29.1 | — | 1.5× | -0.2% | −0.0σ |
| 146 | IRMD | iRadimed Corporation | Healthcare | 28.5 | 46.8× | 12.8× | 2.2% | +0.8σ |
| 147 | COHR | Coherent Corp. | Healthcare | 27.7 | 126× | 8.9× | 0.1% | −1.1σ |
| 148 | ONTO | Onto Innovation Inc. | Healthcare | 27.7 | 97.2×FY | 12.9× | 1.8% | −0.9σ |
| 149 | KMTS | Kestra Medical Technologies, Ltd. Common Stock | Healthcare | 26.3 | — | 17.9× | -7.4% | — |
| 150 | BLFS | BioLife Solutions Inc. | Healthcare | 25.7 | — | 17.8× | 0.5% | +1.0σ |
"Cheap composite" is a 0–100 position among valid sector peers — the mean of the component metrics' sector percentiles. "—" means the scan published no figure, deliberately. "n/a — masked" means the metric is misleading in that name's sector (a REIT's GAAP P/E, a bank's FCF yield) — hover for the reason, which comes from the same sector-validity rules the composite itself respects. An FY tag marks a trailing-year figure built from an annual filing; hover for what that means.